This website uses cookies to ensure you get the best experience
NR-2 Ab ELISE
A2EIN*
NR-2 Ab ELISE - Accurately quantifies NR2 antibodies linked to cerebral ischemia, aiding early identification ofstroke risk, particularly valuable for patients with conditions such as diabetes, hypertension, andcardiovascular diseases.
Predictive Biomarker
Elevated NR2 antibody levels reliably predict increased risk of near-term ischemic stroke or transient ischemic attacks (TIAs), providing essential information for proactive patient management.
User-friendly and Efficient
Designed for straightforward laboratory implementation with clear instructions, standardized controls, and streamlined assay procedure.
High Sensitivity and Precision
Demonstrates a low detection limit (0.7 ng/mL) and excellent precision, ensuring reliable and reproducible results.
Clinically Validated
Supported by multiple scientific studies and clinical trials confirming its efficacy and clinical relevance as a stroke biomarker
Robust and Specific
Exhibits no cross‐reactivity with other common neurological antigens, ensuring high specificity and accuracy in detecting antibodies to the NR2 subunit
We are a leading firm in providing quality and value to our customers. Each member of our team has at least 5 years of legal experience. We love what we do.
Our managers are always ready to answer your questions. You can call us during the weekends and at night. Also, you can visit our office for a personal consultation.